Literature DB >> 25774358

Pathogenesis, management and prevention of atypical femoral fractures.

Gun-Il Im1, Seung-Hyo Jeong1.   

Abstract

Much attention has been paid to the relationship between atypical femoral fractures (AFF) and use of bisphosphonates (BPs). While a significant cause-effect relationship was not established in earlier studies, more recent data shows a growing relationship between AFF and BPs use. The definition of an 'AFF' has also undergone significant changes. This review briefly summarizes the definition, pathogenesis, and management of AFF.

Entities:  

Keywords:  Bone remodeling; Diphosphonates; Femoral fractures

Year:  2015        PMID: 25774358      PMCID: PMC4357631          DOI: 10.11005/jbm.2015.22.1.1

Source DB:  PubMed          Journal:  J Bone Metab        ISSN: 2287-6375


  39 in total

1.  Influence of nonenzymatic glycation on biomechanical properties of cortical bone.

Authors:  D Vashishth; G J Gibson; J I Khoury; M B Schaffler; J Kimura; D P Fyhrie
Journal:  Bone       Date:  2001-02       Impact factor: 4.398

2.  Effects of non-enzymatic glycation on cancellous bone fragility.

Authors:  S Y Tang; U Zeenath; D Vashishth
Journal:  Bone       Date:  2006-12-21       Impact factor: 4.398

3.  Bone material properties in trabecular bone from human iliac crest biopsies after 3- and 5-year treatment with risedronate.

Authors:  Erich Durchschlag; Eleftherios P Paschalis; Ruth Zoehrer; Paul Roschger; Peter Fratzl; Robert Recker; Roger Phipps; Klaus Klaushofer
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

4.  Human femoral neck has less cellular periosteum, and more mineralized periosteum, than femoral diaphyseal bone.

Authors:  Matthew R Allen; David B Burr
Journal:  Bone       Date:  2005-02       Impact factor: 4.398

5.  Trabecular bone volume and microdamage accumulation in the femoral heads of women with and without femoral neck fractures.

Authors:  S Mori; R Harruff; W Ambrosius; D B Burr
Journal:  Bone       Date:  1997-12       Impact factor: 4.398

6.  Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls.

Authors:  Jörg Schilcher; Veronika Koeppen; Jonas Ranstam; Ralf Skripitz; Karl Michaëlsson; Per Aspenberg
Journal:  Bone       Date:  2012-10-22       Impact factor: 4.398

7.  Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: a bone biopsy study.

Authors:  Roland D Chapurlat; Monique Arlot; Brigitte Burt-Pichat; Pascale Chavassieux; Jean Paul Roux; Nathalie Portero-Muzy; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2007-10       Impact factor: 6.741

Review 8.  Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research.

Authors:  Elizabeth Shane; David Burr; Bo Abrahamsen; Robert A Adler; Thomas D Brown; Angela M Cheung; Felicia Cosman; Jeffrey R Curtis; Richard Dell; David W Dempster; Peter R Ebeling; Thomas A Einhorn; Harry K Genant; Piet Geusens; Klaus Klaushofer; Joseph M Lane; Fergus McKiernan; Ross McKinney; Alvin Ng; Jeri Nieves; Regis O'Keefe; Socrates Papapoulos; Tet Sen Howe; Marjolein C H van der Meulen; Robert S Weinstein; Michael P Whyte
Journal:  J Bone Miner Res       Date:  2013-10-01       Impact factor: 6.741

9.  Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment.

Authors:  Matthew R Allen; David B Burr
Journal:  J Bone Miner Res       Date:  2007-11       Impact factor: 6.741

10.  Age-related changes in the collagen network and toughness of bone.

Authors:  X Wang; X Shen; X Li; C Mauli Agrawal
Journal:  Bone       Date:  2002-07       Impact factor: 4.398

View more
  10 in total

1.  High and pointed type of femoral localized reaction frequently extends to complete and incomplete atypical femoral fracture in patients with autoimmune diseases on long-term glucocorticoids and bisphosphonates.

Authors:  H Sato; N Kondo; T Nakatsue; Y Wada; J Fujisawa; J J Kazama; T Kuroda; Y Suzuki; M Nakano; N Endo; I Narita
Journal:  Osteoporos Int       Date:  2017-04-13       Impact factor: 4.507

2.  The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates.

Authors:  H Sato; N Kondo; Y Wada; T Nakatsue; S Iguchi; J Fujisawa; J J Kazama; T Kuroda; M Nakano; N Endo; I Narita
Journal:  Osteoporos Int       Date:  2015-10-30       Impact factor: 4.507

3.  A review of atypical subtrochanteric femoral fractures in Northern Ireland between 2010 and 2014.

Authors:  K J Donnelly; A Tucker; B Kerr; S McDonald; D S O'Longain; J D Acton
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-12-22

4.  Exon array analysis reveals genetic heterogeneity in atypical femoral fractures. A pilot study.

Authors:  Isabel Pérez-Núñez; José L Pérez-Castrillón; María T Zarrabeitia; Carmen García-Ibarbia; Laura Martínez-Calvo; José M Olmos; Laisa S Briongos; Javier Riancho; Victoria Camarero; Josep M Muñoz Vives; Raquel Cruz; José A Riancho
Journal:  Mol Cell Biochem       Date:  2015-07-10       Impact factor: 3.396

5.  Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat.

Authors:  Jean-Daniel Kün-Darbois; Hélène Libouban; Guillaume Mabilleau; Florence Pascaretti-Grizon; Daniel Chappard
Journal:  Clin Oral Investig       Date:  2018-02-16       Impact factor: 3.573

6.  Localization of Atypical Femoral Fracture on Straight and Bowed Femurs.

Authors:  Young-Chang Park; Soon-Phil Yoon; Kyu Hyun Yang
Journal:  J Bone Metab       Date:  2019-05-31

7.  Bone-Targeting AAV-Mediated Gene Silencing in Osteoclasts for Osteoporosis Therapy.

Authors:  Yeon-Suk Yang; Jun Xie; Sachin Chaugule; Dan Wang; Jung-Min Kim; JiHea Kim; Phillip W L Tai; Seok-Kyo Seo; Ellen Gravallese; Guangping Gao; Jae-Hyuck Shim
Journal:  Mol Ther Methods Clin Dev       Date:  2020-04-18       Impact factor: 6.698

Review 8.  Atypical Femoral Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research.

Authors:  Kyu Hyun Yang; Byung Woo Min; Yong-Chan Ha
Journal:  J Bone Metab       Date:  2015-08-31

9.  Incidence Rate of Atypical Femoral Fracture after Bisphosphonates Treatment in Korea.

Authors:  Young Kyun Lee; Soyeon Ahn; Kyoung Min Kim; Chang Suk Suh; Kyung Hoi Koo
Journal:  J Korean Med Sci       Date:  2018-01-29       Impact factor: 2.153

Review 10.  Atypical femoral fractures and current management.

Authors:  Nianye Zheng; Ning Tang; Ling Qin
Journal:  J Orthop Translat       Date:  2016-07-05       Impact factor: 5.191

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.